Rational Advisors LLC Dexcom Inc Transaction History

Rational Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $27,478 - $45,194	364 New	364 $45,000
Q4 2020 Feb 05, 2021	SELL	$78.0 - $104.5 $1,170 - $1,567	-15 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $8,500 - $10,052	-89 Reduced 85.58%	15 $6,000
Q2 2020 Aug 10, 2020	BUY	$62.68 - $105.34 $6,518 - $10,955	104 New	104 $42,000
Q3 2019 Nov 06, 2019	SELL	$35.53 - $43.8 $288,041 - $355,086	-8,107 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$27.84 - $38.92 $225,698 - $315,524	8,107 New	8,107 $1.22 Million

1,084

352M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.2B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Rational Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Rational Advisors LLC with notifications on news.